Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia
- PMID: 7522710
- DOI: 10.1016/0964-1955(94)90085-x
Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia
Abstract
The major value of intermediate filaments (IFs) in biological and applied research lies in their high order of cell and tissue specificity. This is particularly well illustrated in keratin (K) expression in various oral epithelia. Although the original class of IF is usually conserved in tissues after neoplastic transformation, epithelia show a tendency to shift their pattern of keratin expression in a manner which, while not predictable with precision, may sometimes be of diagnostic or prognostic significance. This review compares the keratins in normal oral epithelia, which show a mainly site-dependent expression, with those in squamous cell carcinoma. Key changes in the latter are the presence of simple epithelial keratins, K8 and K18 (occasional K7), reduced expression of differentiation-linked keratins (K1, K10, K4 and K13) and a tendency for down-regulation of primary keratins, K5 and K14. Moderate and severe dysplasias also tend to exhibit K8 and K18 with concomitant disordered expression of differentiation-linked keratins. There are reports of similar changes after neoplastic transformation in other mucosal sites and skin. Before this information can be applied diagnostically in immunocytochemical studies, the anti-keratin antibodies must be fully characterised and their interaction with the relevant tissue, both frozen and conventionally processed, should be evaluated.
Similar articles
-
Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.J Oral Pathol Med. 1992 Jan;21(1):7-11. doi: 10.1111/j.1600-0714.1992.tb00960.x. J Oral Pathol Med. 1992. PMID: 1375644
-
Expression of keratins in normal, immortalized and malignant oral epithelia in organotypic culture.Oral Oncol. 2001 Jul;37(5):419-30. doi: 10.1016/s1368-8375(00)00089-0. Oral Oncol. 2001. PMID: 11377230
-
Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma.Oral Oncol. 2001 Apr;37(3):251-61. doi: 10.1016/s1368-8375(00)00094-4. Oral Oncol. 2001. PMID: 11287279
-
Keratins in health and disease.Curr Opin Cell Biol. 2015 Feb;32:73-81. doi: 10.1016/j.ceb.2014.12.008. Epub 2015 Jan 17. Curr Opin Cell Biol. 2015. PMID: 25599598 Review.
-
The molecular genetics of keratin disorders.Am J Clin Dermatol. 2003;4(5):347-64. doi: 10.2165/00128071-200304050-00005. Am J Clin Dermatol. 2003. PMID: 12688839 Review.
Cited by
-
Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.Virchows Arch. 1997 Mar;430(3):239-45. doi: 10.1007/BF01324808. Virchows Arch. 1997. PMID: 9099982
-
Syringic acid may attenuate the oral mucosal carcinogenesis via improving cell surface glycoconjugation and modifying cytokeratin expression.Toxicol Rep. 2018 Oct 28;5:1098-1106. doi: 10.1016/j.toxrep.2018.10.015. eCollection 2018. Toxicol Rep. 2018. PMID: 30425931 Free PMC article.
-
Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity.BMC Cancer. 2006 Jan 13;6:10. doi: 10.1186/1471-2407-6-10. BMC Cancer. 2006. PMID: 16412231 Free PMC article.
-
Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.Antivir Ther. 2010;15(2):253-65. doi: 10.3851/IMP1512. Antivir Ther. 2010. PMID: 20386081 Free PMC article.
-
Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization.Am J Pathol. 2003 Mar;162(3):963-75. doi: 10.1016/S0002-9440(10)63891-6. Am J Pathol. 2003. PMID: 12598329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous